1-{[4-chloro-5-(thiophen-2-yl)thieno[2,3-d]pyrimidin-2-yl]methyl}-4-methylpiperidine

Catalog No. :
ACIVTA865
CAS No. :
885460-55-9
Molecular Formula :
C17H18ClN3S2
Molecular Weight :
363.94

IUPAC Name:4-chloro-2-((4-methylpiperidin-1-yl)methyl)-5-(thiophen-2-yl)thieno[2,3-d]pyrimidine

1-{[4-chloro-5-(thiophen-2-yl)thieno[2,3-d]pyrimidin-2-yl]methyl}-4-methylpiperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$287.00Login to see priceInquiryInquiry
5g95%$835.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-{[4-chloro-5-(thiophen-2-yl)thieno[2,3-d]pyrimidin-2-yl]methyl}-4-methylpiperidine
IUPAC Name4-chloro-2-((4-methylpiperidin-1-yl)methyl)-5-(thiophen-2-yl)thieno[2,3-d]pyrimidine
MDL No.MFCD06660717
Molecular FormulaC17H18ClN3S2
Molecular Weight363.94
SMILESCC1CCN(CC2=NC(Cl)=C(C(C3=CC=CS3)=CS4)C4=N2)CC1
InChI KeyNKMFSOJSFYRWHJ-UHFFFAOYSA-N
SynonymThieno[2,3-d]pyrimidine, 4-chloro-2-[(4-methyl-1-piperidinyl)methyl]-5-(2-thienyl)-
CAS No.885460-55-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIVTA865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVTA865 route product structure diagram
    ACIVTA865885460-55-9
Inquiry

2. ACIVTA865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVTA865 route product structure diagram
    ACIVTA865885460-55-9
Inquiry

Comments (0)